We postulate that changes in IGF2 levels and/or IGF2 signaling could prevent to the differential neuronal vulnerability of dopaminergic neurons, motor impairment and α-syn accumulation in PD and arise as a potential neuroprotective factor to prevent the dopaminergic neuronal loss on PD. Here, IGF2 is linked to Parkinson disease.